The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 411.40
Bid: 410.60
Ask: 411.40
Change: -13.00 (-3.06%)
Spread: 0.80 (0.195%)
Open: 415.00
High: 418.20
Low: 409.20
Prev. Close: 424.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of President and CEO of QinetiQ US

17 Jan 2022 07:00

RNS Number : 5554Y
QinetiQ Group plc
17 January 2022
 

News release

QinetiQ Group plc

Shawn Purvis appointed President and CEO of QinetiQ US

17 January 2022 - QinetiQ Group plc ("QinetiQ" or "the Group") today names Shawn Purvis as President and CEO of QinetiQ US, effective 16 February 2022.

Shawn is currently a member of the Executive Leadership Team and Corporate Vice President at Northrop Grumman Corporation. Shawn leads Northrop Grumman's Enterprise Services sector, responsible for global cyber security, operations and next generation digitisation including digital design for engineering, production and manufacturing operations. Over the course of Shawn's 25+ years of P&L responsibilities, she has led billion-dollar organisations in the areas of defence, intelligence and cyber security technical solutions in support of the warfighter and intelligence customers both domestic and global, achieving organic revenue growth and margin improvement year over year. Her experience also includes the functional integration of a multi-billion dollar acquisition. As CEO of QinetiQ US, Shawn will be responsible for the complete operations of the business while transforming QinetiQ US into a world class provider of innovative defence and security solutions.

Shawn's extensive experience includes strategic, financial, engineering, operations and customer focused leadership positions within Lockheed Martin, Science Applications International Corporation (SAIC) and Northrop Grumman. Shawn holds a Master of Science (MSc) in Information Systems and was named as one of the Top 25 Executives to Watch in 2020/2021 by Washington Exec and a first time WASH100 winner in 2021. Shawn will join QinetiQ's Global Leadership Team led by Steve Wadey, QinetiQ's Group CEO and also join the QinetiQ Inc. Board.

Neil Johnson, Chairman of QinetiQ, commented:

"On behalf of the QinetiQ Group plc Board, I am very pleased to welcome Shawn to the Group. Shawn brings extensive executive level experience both in leading complex P&L organisations in the US and in integrating substantial businesses successfully. She has a proven track record for delivering programme execution, strategy and growth, and will be a significant asset to the leadership team."

Steve Wadey, Group CEO of QinetiQ, commented:

"With more than 25 years of experience in the US defence and intelligence industry and a track record of transformational leadership, driving P&L performance of complex organisations and large scale acquisition integration, Shawn is the right leader to build our disruptive mid-tier company in the US by supporting and protecting the US warfighter. Shawn's proven leadership skills are perfectly aligned to delivering both our short-term operational and financial performance and realising our long-term ambition to more than double the size of our US business over the next 5 years."

 Shawn Purvis, incoming President and CEO of QinetiQ US, commented:

"I am incredibly honoured and excited to be given the opportunity to lead the talented and dedicated people who make up our QinetiQ US business, as we continue to deliver mission critical sensing and robotic capabilities for the US warfighter. With an ambition to build a disruptive mid-tier company in the US through both organic growth and strategy-led acquisitions, I am focused on driving both strong operational performance and executing on our growth strategy for the medium and long-term."

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Chris Barrie, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7968 727289

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFLFDMEESEFF
Date   Source Headline
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.